MedTrace Logo

Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula

NCT03991949 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2022-12-13

No results posted yet for this study

Summary

This single-group study will assess growth and tolerance of infants fed a post-discharge preterm infant formula containing a prebiotic.

Conditions

  • Infant Development

Interventions

OTHER

Experimental Infant Formula

Formula fed Ad libitum

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Michelle Johnson, RDN, LD · Abbott Nutrition

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
34 Weeks
Max Age
41 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-04
Primary Completion
2022-11-16
Completion
2022-11-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03991949 on ClinicalTrials.gov